LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,573 | -45.1% | 28,049 | +15.4% | 0.00% | – |
| Q2 2023 | $55,681 | +0.1% | 24,315 | +6.2% | 0.00% | – |
| Q1 2023 | $55,613 | +10.6% | 22,886 | -13.1% | 0.00% | – |
| Q4 2022 | $50,279 | -14.8% | 26,324 | +6.9% | 0.00% | – |
| Q3 2022 | $59,000 | +59.5% | 24,625 | +24.2% | 0.00% | – |
| Q2 2022 | $37,000 | -38.3% | 19,832 | -30.5% | 0.00% | – |
| Q1 2022 | $60,000 | -58.0% | 28,535 | -21.3% | 0.00% | – |
| Q4 2021 | $143,000 | +76.5% | 36,257 | +105.9% | 0.00% | – |
| Q2 2021 | $81,000 | +3.8% | 17,612 | +32.5% | 0.00% | – |
| Q1 2021 | $78,000 | +143.8% | 13,289 | -40.5% | 0.00% | – |
| Q3 2020 | $32,000 | -28.9% | 22,321 | -1.7% | 0.00% | – |
| Q2 2020 | $45,000 | +36.4% | 22,702 | +33.0% | 0.00% | – |
| Q1 2020 | $33,000 | -72.3% | 17,073 | -40.3% | 0.00% | -100.0% |
| Q4 2019 | $119,000 | +17.8% | 28,607 | -14.6% | 0.00% | 0.0% |
| Q3 2019 | $101,000 | -54.9% | 33,496 | -5.9% | 0.00% | 0.0% |
| Q2 2019 | $224,000 | -0.9% | 35,598 | -12.5% | 0.00% | 0.0% |
| Q1 2019 | $226,000 | -16.0% | 40,683 | +0.6% | 0.00% | -50.0% |
| Q4 2018 | $269,000 | -48.0% | 40,442 | -16.6% | 0.00% | -50.0% |
| Q3 2018 | $517,000 | -14.1% | 48,464 | -3.4% | 0.00% | 0.0% |
| Q2 2018 | $602,000 | +29.2% | 50,167 | -7.7% | 0.00% | +33.3% |
| Q1 2018 | $466,000 | -25.4% | 54,327 | -14.1% | 0.00% | -25.0% |
| Q4 2017 | $625,000 | -18.5% | 63,281 | +1.4% | 0.00% | -42.9% |
| Q3 2017 | $767,000 | -19.3% | 62,430 | +8.0% | 0.01% | -22.2% |
| Q2 2017 | $951,000 | +9.8% | 57,826 | -4.3% | 0.01% | 0.0% |
| Q1 2017 | $866,000 | -17.0% | 60,400 | -20.0% | 0.01% | -25.0% |
| Q4 2016 | $1,044,000 | -18.6% | 75,519 | +6.4% | 0.01% | -33.3% |
| Q3 2016 | $1,283,000 | +8.5% | 71,002 | -13.9% | 0.02% | +20.0% |
| Q2 2016 | $1,183,000 | +21.1% | 82,453 | +0.8% | 0.02% | +15.4% |
| Q1 2016 | $977,000 | -17.9% | 81,790 | -8.5% | 0.01% | -7.1% |
| Q4 2015 | $1,190,000 | +33.6% | 89,382 | +7.7% | 0.01% | +7.7% |
| Q3 2015 | $891,000 | +25.7% | 82,992 | -5.7% | 0.01% | +30.0% |
| Q2 2015 | $709,000 | – | 88,031 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |